According to Statista, China has already surpassed the US to become the largest OTC pharmaceutical market in the world.  The OTC drug revenue in China is expected to be US$27.28bn in 2022.  China has issued pilot policies that support the import of OTC drugs via cross-border e-commerce (CBEC).  This event will feature an analysis of China's OTC pharmaceuticals CBEC market (with Tmall as an example), provide steps on how to set up and manage a CBEC store, as well as cover a case study.